hypochlorous acid has been researched along with Cirrhosis in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 14 (77.78) | 24.3611 |
| 2020's | 4 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Ge, Y; Hu, L; Huang, J; Li, C; Li, D; Li, Y; Lin, X; Luo, J; Man, M; Yu, H; Zhang, J | 1 |
| Kohan, L; Mohammadi, M; Mohammadi, S; Saeidi, M; Saghaeian Jazi, M | 1 |
| Hu, Y; Jennings, S; Luo, M; Nauseef, WM; Scull, C; Taylor, CM; Wang, G; Wellems, D | 1 |
| Colmegna, I; Fraser, R; Fujii, U; Joy, S; Martin, JG; Morozan, A; Watters, K | 1 |
| Chen, W; Du, Q; Meng, M; Tan, J; Wang, K; Wang, N; Xie, B; Zhu, H | 1 |
| Chen, SQ; Chen, XW; Chen, YH; Liu, YJ; Liu, ZR; Niu, HX; Tang, DD; Zhao, H; Zhou, RN | 1 |
| Batteux, F; Cerles, O; Chéreau, C; Chouzenoux, S; Kavian, N; Morin, F; Nicco, C | 1 |
| Batteux, F; Borderie, D; Guilpain, P; Hilhorst, M; Kavian, N; Le Quellec, A; Maria, AT; van Paassen, P | 1 |
| Altavilla, D; Atteritano, M; Bagnato, G; Bitto, A; Cinquegrani, M; Irrera, N; Pizzino, G; Roberts, W; Saitta, A; Sangari, D; Squadrito, F | 1 |
| Anwar, A; Batteux, F; Chéreau, C; Eggleton, P; Jacob, C; Jamier, V; Kavian, N; Marut, W; Nicco, C; Servettaz, A; Weill, B; Winyard, PG | 1 |
| Chang, FC; Chang, YT; Chen, YM; Chen, YT; Chiang, WC; Chou, YH; Duffield, JS; Lin, SL; Liu, YH; Pan, SY; Tsai, TJ; Wu, KD; Yeh, PY | 1 |
| Batteux, F; Bony, C; Guilpain, P; Jorgensen, C; Le Quellec, A; Maria, AT; Noël, D; Petit, B; Pirot, N; Roger, P; Toupet, K; Vozenin, MC | 1 |
| Böhm, M; Haub, J; Lorenz, N; Ook, KY; Raker, VK; Schmidt, T; Schuppan, D; Stegemann, A; Steinbrink, K | 1 |
| Batteux, F; Cerles, O; Chéreau, C; Kavian, N; Morin, F; Nicco, C | 1 |
| Batteux, F; Chéreau, C; Deveaux, V; Kavian, N; Lotersztajn, S; Nicco, C; Servettaz, A; Wang, A; Weill, B; Zimmer, A | 1 |
| Batteux, F; Kavian, N; Servettaz, A | 1 |
| Ba, LA; Batteux, F; Chéreau, C; Doering, M; Jacob, C; Kavian, N; Marut, WK; Nicco, C; Servettaz, A; Weill, B | 1 |
| Batteux, F; Chéreau, C; Dinh-Xuan, AT; Hua-Huy, T; Kavian, N; Marut, W; Nicco, C; Servettaz, A; Weill, B | 1 |
1 review(s) available for hypochlorous acid and Cirrhosis
| Article | Year |
|---|---|
New insights on chemically induced animal models of systemic sclerosis.
Topics: Animals; Autoimmunity; Bleomycin; Disease Models, Animal; Fibrosis; Humans; Hypochlorous Acid; Inflammation; Mice; Reactive Oxygen Species; Scleroderma, Systemic | 2011 |
17 other study(ies) available for hypochlorous acid and Cirrhosis
| Article | Year |
|---|---|
Deficiency of vitamin D receptor in keratinocytes augments dermal fibrosis and inflammation in a mouse model of HOCl-induced scleroderma.
Topics: Animals; Collagen; Dermis; Disease Models, Animal; Fibrosis; Hypochlorous Acid; Inflammation; Keratinocytes; Mice, Inbred C57BL; Mice, Knockout; Receptors, Calcitriol; Skin Diseases; Up-Regulation | 2022 |
The antifibrotic effects of
Topics: Animals; Anti-Inflammatory Agents; Collagen; Dimethyl Sulfoxide; Disease Models, Animal; Female; Fibrosis; Flavanones; Hypochlorous Acid; Mice; Mice, Inbred BALB C; RNA, Messenger; Skin Diseases; Transforming Growth Factor beta | 2022 |
Neutrophil defect and lung pathogen selection in cystic fibrosis.
Topics: Animals; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Fibrosis; Hypochlorous Acid; Lung; Mice; Neutrophils; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcus aureus | 2023 |
Superiority of systemic bleomycin to intradermal HOCl for the study of interstitial lung disease.
Topics: Animals; Bleomycin; Disease Models, Animal; Fibrosis; Hypochlorous Acid; Lung; Lung Diseases, Interstitial; Mice; NF-E2-Related Factor 2; Pulmonary Fibrosis; Scleroderma, Systemic; Skin | 2023 |
The Fibrosis and Immunological Features of Hypochlorous Acid Induced Mouse Model of Systemic Sclerosis.
Topics: Animals; Disease Models, Animal; Fibrosis; Hypochlorous Acid; Lung; Mice; Mice, Inbred BALB C; Oxidants; Scleroderma, Systemic; Skin | 2019 |
Role of mitochondrial dysfunction in renal fibrosis promoted by hypochlorite-modified albumin in a remnant kidney model and protective effects of antioxidant peptide SS-31.
Topics: Animals; Antioxidants; Biomarkers; Cytoprotection; Extracellular Matrix; Fibrosis; Hypochlorous Acid; Kidney; Mitochondria; Oligopeptides; Oxidative Stress; Rats, Sprague-Dawley; Serum Albumin; Up-Regulation | 2017 |
Leflunomide prevents ROS-induced systemic fibrosis in mice.
Topics: Animals; Antirheumatic Agents; Autoantibodies; Bleomycin; Cells, Cultured; Disease Models, Animal; Female; Fibrosis; Humans; Hypochlorous Acid; Immunosuppression Therapy; Isoxazoles; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Leflunomide; Lymphocyte Activation; Macrophages; Mice; Mice, Inbred BALB C; Pulmonary Fibrosis; Reactive Oxygen Species; Signal Transduction; Skin; STAT6 Transcription Factor | 2017 |
Impact of MPO-ANCA-mediated oxidative imbalance on renal vasculitis.
Topics: Advanced Oxidation Protein Products; Aged; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Antineutrophil Cytoplasmic; Biomarkers; Enzyme Activation; Female; Fibrosis; Glomerulonephritis; Humans; Hypochlorous Acid; Kidney; Kidney Diseases; Male; Middle Aged; Oxidative Stress; Peroxidase; Prospective Studies; Registries; Sulfhydryl Compounds | 2018 |
Propylthiouracil prevents cutaneous and pulmonary fibrosis in the reactive oxygen species murine model of systemic sclerosis.
Topics: Actins; Animals; Antithyroid Agents; Blotting, Western; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; Female; Fibrosis; Hypochlorous Acid; Hypothyroidism; Immunohistochemistry; Mice; Mice, Inbred BALB C; Muscle, Smooth; Oxidants; Propylthiouracil; Pulmonary Fibrosis; Random Allocation; ras Proteins; Scleroderma, Systemic; Skin; Thyrotropin; Thyroxine; Triiodothyronine; Vascular Endothelial Growth Factor A | 2013 |
The natural organosulfur compound dipropyltetrasulfide prevents HOCl-induced systemic sclerosis in the mouse.
Topics: Actins; Animals; Apoptosis; Autoantibodies; Cell Proliferation; Cells, Cultured; Collagen; DNA Topoisomerases, Type I; Dose-Response Relationship, Drug; Female; Fibroblasts; Fibrosis; Flow Cytometry; Hydrogen Peroxide; Hypochlorous Acid; Interleukin-13; Interleukin-4; Lung; Lymphocytes; Mice; Mice, Inbred BALB C; Scleroderma, Systemic; Skin; Smad Proteins; Sulfides | 2013 |
Lineage tracing reveals distinctive fates for mesothelial cells and submesothelial fibroblasts during peritoneal injury.
Topics: Animals; Cell Lineage; Collagen Type I; Collagen Type I, alpha 1 Chain; Epithelial Cells; Epithelium; Fibroblasts; Fibrosis; Genes, Reporter; Genetic Markers; Green Fluorescent Proteins; Hypochlorous Acid; Mice; Mice, Inbred C57BL; Mice, Transgenic; Peritoneal Fibrosis; Peritoneum; Tamoxifen; Transforming Growth Factor beta1 | 2014 |
Antifibrotic, Antioxidant, and Immunomodulatory Effects of Mesenchymal Stem Cells in HOCl-Induced Systemic Sclerosis.
Topics: Actins; Animals; Autoantibodies; Collagen Type I; Collagen Type III; Disease Models, Animal; DNA Topoisomerases, Type I; Enzyme-Linked Immunosorbent Assay; Fibrosis; Hypochlorous Acid; Lung; Mesenchymal Stem Cell Transplantation; Mice; Oxidants; Oxidative Stress; Pulmonary Fibrosis; Reverse Transcriptase Polymerase Chain Reaction; Scleroderma, Diffuse; Skin; Transcriptome; Transforming Growth Factor beta1 | 2016 |
Myeloid cell populations and fibrogenic parameters in bleomycin- and HOCl-induced fibrosis.
Topics: Animals; Bleomycin; Disease Models, Animal; Female; Fibrosis; Hypochlorous Acid; Mice, Inbred C57BL; Myeloid Cells; Scleroderma, Systemic; Skin | 2016 |
Niclosamide Prevents Systemic Sclerosis in a Reactive Oxygen Species-Induced Mouse Model.
Topics: Animals; Anthelmintics; Autoantibodies; B-Lymphocytes; Bleomycin; Cells, Cultured; Cytokines; Disease Models, Animal; DNA Topoisomerases, Type I; Female; Fibrosis; Humans; Hypochlorous Acid; Lung; Mice; Mice, Inbred BALB C; Niclosamide; Reactive Oxygen Species; Scleroderma, Systemic; Signal Transduction; Skin; T-Lymphocytes | 2016 |
Targeting the cannabinoid pathway limits the development of fibrosis and autoimmunity in a mouse model of systemic sclerosis.
Topics: Analgesics; Animals; Autoantibodies; Autoimmunity; Benzoxazines; Cannabinoids; Cell Proliferation; Cells, Cultured; Disease Models, Animal; DNA Topoisomerases, Type I; Female; Fibroblasts; Fibrosis; Humans; Hypochlorous Acid; Lung; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Morpholines; Naphthalenes; Oxidants; Random Allocation; Receptor, Cannabinoid, CB2; Scleroderma, Systemic; Signal Transduction; Skin | 2010 |
The organotelluride catalyst (PHTE)₂NQ prevents HOCl-induced systemic sclerosis in mouse.
Topics: Actins; Animals; Autoantibodies; Cells, Cultured; Disease Models, Animal; DNA Topoisomerases, Type I; Female; Fibroblasts; Fibrosis; Glutathione; Hydrogen Peroxide; Hypochlorous Acid; In Vitro Techniques; Mice; Mice, Inbred BALB C; Naphthoquinones; Nitric Oxide; Organometallic Compounds; Reactive Oxygen Species; Scleroderma, Systemic; Skin; Tellurium | 2012 |
Amelioration of systemic fibrosis in mice by angiotensin II receptor blockade.
Topics: Administration, Oral; Angiotensin II Type 1 Receptor Blockers; Animals; Biomarkers; Biphenyl Compounds; Breath Tests; Disease Models, Animal; Female; Fibrosis; Hypochlorous Acid; Injections, Intradermal; Irbesartan; Lung; Mice; Mice, Inbred BALB C; Nitric Oxide; Nitric Oxide Synthase Type II; Oxidants; Pulmonary Fibrosis; Scleroderma, Systemic; Skin; Tetrazoles; Tyrosine | 2013 |